{
    "medicine_id": "d2d9b1f2d5fa0be233681a730f7c60b08eb325af",
    "platform_id": "DB08907",
    "metadata": {
        "name": "Invokamet 100 mg Tablet",
        "composition": "100 mg Canagliflozin",
        "clinical_particulars": {
            "therapeutic_indications": "This drug is used in conjunction with diet and exercise to increase glycemic control in adults diagnosed with type 2 diabetes mellitus FDA label Another indication for canagliflozin is the prevention of major cardiovascular events myocardial infarction stroke or death due to a cardiovascular cause in patients with type 2 diabetes as well as hospitalization for heart failure in patients with type 2 diabetes L5897 L8917 In addition to the above canagliflozin can be used to lower the risk of end stage kidney disease and major increases in serum creatinine and cardiovascular death for patients with a combination of type 2 diabetes mellitus diabetic nephropathy and albuminuria L8917 It is important to note that this drug is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis FDA label",
            "contraindications": {
                "disease": "Overdose information If an overdose occurs contact the Poison Control Center Normal supportive measures should be taken including the removal unabsorbed drug from the gastrointestinal tract initiating clinical monitoring of the patient and providing supportive treatment as deemed necessary Canagliflozin has been removed in very small quantities after a 4 hour hemodialysis session This drug is likely not dialyzable by peritoneal dialysis FDA label Pregnancy and lactation Animal data has demonstrated that canagliflozin may cause adverse renal effects in a growing fetus Data are insufficient at this time in determining a potential canagliflozin related risk for major birth defects or possible miscarriage in humans FDA Label There are known risks however of uncontrolled diabetes in pregnancy FDA label Inform female patients taking canagliflozin of the potential risk which is increased during the second and third trimesters This drug is not recommended during nursing FDA label Mutagenesis and carcinogenicity Canagliflozin was not found to be mutagenic in both metabolically activated and inactivated states in the Ames assay Canagliflozin showed mutagenicity in laboratory mouse lymphoma assay but only in the activated state Canagliflozin was not found to be mutagenic in several _in vivo_ assays performed on rats FDA label The carcinogenic risk of canagliflozin was assessed in 2 year studies completed in both CD1 mice and Sprague Dawley rats Canagliflozin was not shown to increase tumor incidence in mouse models given doses less than or equal to 14 times the exposure from a typical 300 mg dose in humans Despite these negative findings in mice the incidence of several tumors increased in mice including Leydig cell tumors renal tubular adenomas and adrenal pheochromocytomas FDA label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "This drug increases urinary glucose excretion and decreases the renal threshold for glucose RTG in a dose dependent manner FDA label The renal threshold is defined as the lowest level of blood glucose associated with the appearance of detectable glucose in the urine A176969 T545 The end result of canagliflozin administration is increased urinary excretion of glucose and less renal absorption of glucose decreasing glucose concentration in the blood and improving glycemic control A note on type 2 diabetes and cardiovascular disease The risk of cardiovascular events in diabetes type 2 is increased due to the damaging effects of diabetes on blood vessels and nerves in the cardiovascular system In particular there is a tendency for hyperglycemia to create pro atherogenic plaque forming lesions in blood vessels leading to various fatal and non fatal events including stroke and myocardial infarction A177086 L5933 Long term glycemic control has been proven to be effective in the prevention of cardiovascular events such as myocardial infarction and stroke in patients with type 2 diabetes A177095",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00082",
                        "description": "The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of orthostatic hypotension and syncope can be increased when Canagliflozin is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of hypotension and orthostatic hypotension can be increased when Canagliflozin is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Canagliflozin may increase the hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Afatinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The serum concentration of Bosutinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The serum concentration of Colchicine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Edoxaban can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Ledipasvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The serum concentration of Naloxegol can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The serum concentration of Pazopanib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The serum concentration of Prucalopride can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Silodosin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The serum concentration of Topotecan can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Valsartan"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Telmisartan"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01342",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Forasartan"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01349",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Tasosartan"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Saralasin"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Azilsartan medoxomil"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Fimasartan"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The risk or severity of hypotension hyperkalemia and reduced intravascular volume can be increased when Canagliflozin is combined with Candesartan"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Trandolaprilat"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Moexiprilat"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Ramipril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Fosinopril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Trandolapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Enalapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Moexipril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Lisinopril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Perindopril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Quinapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Omapatrilat is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Rescinnamine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Cilazapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Spirapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Temocapril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Captopril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB15565",
                        "description": "The risk or severity of renal failure hypotension and hyperkalemia can be increased when Canagliflozin is combined with Cilazaprilat"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Everolimus can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The serum concentration of Rifaximin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Torasemide"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Furosemide"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Piretanide"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "The risk or severity of hypotension can be increased when Canagliflozin is combined with Azosemide"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Canagliflozin can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB00166",
                        "description": "The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Aripiprazole lauroxil may increase the hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may increase the hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Enoxacin"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Pefloxacin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Flumequine"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Enrofloxacin"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Metolazone"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Indapamide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Quinethazone"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Epitizide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The excretion of Vincristine can be decreased when combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The serum concentration of Doxorubicin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "Amoxapine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "Amineptine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "Butriptyline may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "Dosulepin may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "Oxaprotiline may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "Amitriptylinoxide may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "Dibenzepin may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "Quinupramine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "Melitracen may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "Lofepramine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "Iprindole may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "Imipramine oxide may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "Tianeptine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Amitriptyline may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Doxepin may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Desipramine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Clomipramine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the orthostatic hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Acarbose"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Miglitol"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Repaglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Phenformin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glipizide"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Gliclazide"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Mitiglinide"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Exenatide"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Mecasermin"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Pramlintide"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin aspart"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin detemir"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glymidine"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "Canagliflozin may increase the hypoglycemic activities of AICA ribonucleotide"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Buformin"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Vildagliptin"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Voglibose"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "Canagliflozin may increase the hypoglycemic activities of NN344"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "Canagliflozin may increase the hypoglycemic activities of NBI 6024"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "Canagliflozin may increase the hypoglycemic activities of AMG 222"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Bisegliptin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Alogliptin"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Liraglutide"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Benfluorex"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Albiglutide"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Lixisenatide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin beef"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Ipragliflozin"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Allicin"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Tofogliflozin"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "Canagliflozin may increase the hypoglycemic activities of 2 4 thiazolidinedione"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Evogliptin"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Sotagliflozin"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Balaglitazone"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Remogliflozin etabonate"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Carbutamide"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Guar gum"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Metahexamide"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Semaglutide"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Taspoglutide"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Englitazone"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Tirzepatide"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Gastric inhibitory polypeptide"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Glyburide"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Canagliflozin may increase the hypoglycemic activities of Sunitinib"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Etonogestrel"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Desogestrel"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Levonorgestrel"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Niacin"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Norethisterone"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ethynodiol diacetate"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Mestranol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Danazol"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Estrone sulfate"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydroxyprogesterone caproate"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB09009",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Articaine"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dienogest"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Teprotumumab"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Indinavir"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Olanzapine"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Megestrol acetate"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ethinylestradiol"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Atazanavir"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Darunavir"
                    },
                    {
                        "drugbank-id": "DB01319",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Fosamprenavir"
                    },
                    {
                        "drugbank-id": "DB00621",
                        "description": "Oxandrolone may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00984",
                        "description": "Nandrolone phenpropionate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01185",
                        "description": "Fluoxymesterone may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06718",
                        "description": "Stanozolol may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08804",
                        "description": "Nandrolone decanoate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12461",
                        "description": "GLPG 0492 may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13169",
                        "description": "Nandrolone may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13587",
                        "description": "Mesterolone may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "Oxymetholone may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14025",
                        "description": "The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hypoglycemia can be increased when Indalpine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hypoglycemia can be increased when Citalopram is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of hypoglycemia can be increased when Sertraline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09270",
                        "description": "The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "Aminosalicylic acid may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "Bismuth subsalicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "Dersalazine may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "Phenyl aminosalicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "Methyl salicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "Trolamine salicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "Aloxiprin may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Choline salicylate may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "Thiosalicylic acid may increase the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of adverse effects can be increased when Streptokinase is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ropinirole is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when Nabilone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Thioridazine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of adverse effects can be increased when Tizanidine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of adverse effects can be increased when Levosimendan is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Iloprost is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of adverse effects can be increased when Papaverine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "The risk or severity of adverse effects can be increased when Amifostine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Desflurane is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "The risk or severity of adverse effects can be increased when Carbetocin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "The risk or severity of adverse effects can be increased when Nesiritide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Nitrous acid"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Indoramin"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Riociguat"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of adverse effects can be increased when Bupivacaine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Sevoflurane is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of adverse effects can be increased when Rotigotine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Prazosin"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Clonidine"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Terazosin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of adverse effects can be increased when Dipyridamole is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Paclitaxel is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of hyperkalemia can be increased when Esmolol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of hyperkalemia can be increased when Levomenthol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of hyperkalemia can be increased when Heparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of hyperkalemia can be increased when Enoxaparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB02968",
                        "description": "The risk or severity of hyperkalemia can be increased when Penicillin G Acyl Serine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB09261",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Certoparin"
                    },
                    {
                        "drugbank-id": "DB12097",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Mannitol busulfan"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The risk or severity of hyperkalemia can be increased when Canagliflozin is combined with Landiolol"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Canagliflozin may increase the nephrotoxic activities of Sodium phosphate monobasic"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Betrixaban can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Canagliflozin may increase the hypotensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the hypotensive activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Pravastatin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Morphine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The serum concentration of Clobazam can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Mannitol can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Clomifene can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Tegaserod can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Sitagliptin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The serum concentration of Belinostat can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Indacaterol can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Ambrisentan can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Apixaban can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Odanacatib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Dolutegravir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Sofosbuvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Palbociclib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Umeclidinium can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The serum concentration of Lenvatinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The serum concentration of Nintedanib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Technetium Tc 99m sestamibi can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Dasabuvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Ombitasvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Paritaprevir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Selexipag can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The serum concentration of Elbasvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Grazoprevir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Asunaprevir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Velpatasvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Tezacaftor can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The serum concentration of Baricitinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Revefenacin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Valspodar can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The serum concentration of Duvelisib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The serum concentration of Glasdegib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Elagolix can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Avatrombopag can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Voxilaprevir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The serum concentration of Gilteritinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Rucaparib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Grapiprant can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Lusutrombopag can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Pibrentasvir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Glecaprevir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Ivosidenib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Larotrectinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Conivaptan can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Tipranavir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Amiodarone can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Lopinavir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Dronedarone can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Lomitapide can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The serum concentration of Eliglustat can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Entrectinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Fedratinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The serum concentration of Idelalisib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Rifamycin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Enfortumab vedotin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Darolutamide can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The serum concentration of Tazemetostat can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Lemborexant can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Selumetinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Ripretinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Fostemsavir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Remdesivir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Lactulose"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Zinc"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Dantron"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Oxyphenisatin"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Phenolphthalein"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Emodin"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Linaclotide"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Bisacodyl"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Polycarbophil"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium acetate tetrahydrate"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Monopotassium phosphate"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Dipotassium phosphate"
                    },
                    {
                        "drugbank-id": "DB09483",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Potassium lactate"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium fluorophosphate"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Mineral oil"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Carboxymethylcellulose"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Docusate"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Plantago seed"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium citrate"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Castor oil"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium glycinate"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Methylcellulose"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sennosides"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Lactitol"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Plecanatide"
                    },
                    {
                        "drugbank-id": "DB13180",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Gluconic Acid"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium peroxide"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Pentaerithrityl"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium tartrate"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium acetate"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Deacetylbisacodyl"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium ascorbate"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium phosphate dibasic"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium phosphate monobasic unspecified form"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium phosphate dibasic unspecified form"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Magnesium"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sodium cation"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Plantago ovata seed"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Oxyphenisatin acetate"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Konjac mannan"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Alloin"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Frangula purshiana bark"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Polyethylene glycol"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Glycerin"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The risk or severity of adverse effects can be increased when Canagliflozin is combined with Sulfate ion"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Ethoxzolamide"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00576",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamethizole"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00664",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfametopyrazine"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00891",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfapyridine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Diclofenamide"
                    },
                    {
                        "drugbank-id": "DB01298",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfacytine"
                    },
                    {
                        "drugbank-id": "DB01299",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadoxine"
                    },
                    {
                        "drugbank-id": "DB01581",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamerazine"
                    },
                    {
                        "drugbank-id": "DB01582",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamethazine"
                    },
                    {
                        "drugbank-id": "DB04707",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Hydroxyfasudil"
                    },
                    {
                        "drugbank-id": "DB06150",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadimethoxine"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06821",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfameter"
                    },
                    {
                        "drugbank-id": "DB07996",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with 5 2 methylpiperazine 1 sulfonyl isoquinoline"
                    },
                    {
                        "drugbank-id": "DB08162",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Fasudil"
                    },
                    {
                        "drugbank-id": "DB08798",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamoxole"
                    },
                    {
                        "drugbank-id": "DB11389",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Clorsulon"
                    },
                    {
                        "drugbank-id": "DB11461",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfachlorpyridazine"
                    },
                    {
                        "drugbank-id": "DB11462",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaethoxypyridazine"
                    },
                    {
                        "drugbank-id": "DB11463",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfanitran"
                    },
                    {
                        "drugbank-id": "DB11464",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaquinoxaline"
                    },
                    {
                        "drugbank-id": "DB12051",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Setrobuvir"
                    },
                    {
                        "drugbank-id": "DB12921",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Chlorsulfaquinoxaline"
                    },
                    {
                        "drugbank-id": "DB13214",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfadicramide"
                    },
                    {
                        "drugbank-id": "DB13248",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Phthalylsulfathiazole"
                    },
                    {
                        "drugbank-id": "DB13283",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaisodimidine"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Meticrane"
                    },
                    {
                        "drugbank-id": "DB13320",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaperin"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Mefruside"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13485",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfametomidine"
                    },
                    {
                        "drugbank-id": "DB13547",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfatolamide"
                    },
                    {
                        "drugbank-id": "DB13556",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamazone"
                    },
                    {
                        "drugbank-id": "DB13580",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Succinylsulfathiazole"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Clorexolone"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Clofenamide"
                    },
                    {
                        "drugbank-id": "DB13699",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfathiourea"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Fenquizone"
                    },
                    {
                        "drugbank-id": "DB13726",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaguanidine"
                    },
                    {
                        "drugbank-id": "DB13773",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfamethoxypyridazine"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Clopamide"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Xipamide"
                    },
                    {
                        "drugbank-id": "DB14033",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Acetyl sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The therapeutic efficacy of Bosentan can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Dabigatran etexilate can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "Triamterene may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "Rofecoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "Givosiran may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Canagliflozin may decrease the excretion rate of Loxoprofen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Canagliflozin may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Canagliflozin may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Canagliflozin may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Canagliflozin may decrease the excretion rate of Cisplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Canagliflozin may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Canagliflozin may decrease the excretion rate of Procainamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Canagliflozin may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Canagliflozin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Canagliflozin may decrease the excretion rate of Warfarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Potassium chloride may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Clevidipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Ammonium chloride may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canagliflozin may increase the excretion rate of Canrenoic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Canagliflozin may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Canagliflozin may increase the excretion rate of Potassium citrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Canagliflozin may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Canagliflozin may increase the excretion rate of Potassium bicarbonate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canagliflozin may increase the excretion rate of Canrenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Canagliflozin may increase the excretion rate of Potassium acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Canagliflozin may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Canagliflozin may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Canagliflozin may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Tositumomab may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Lorazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Ticlopidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Temazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Benzatropine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Carmustine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Atomoxetine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Ibutilide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "Hydromorphone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "Eszopiclone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Nitric Oxide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Flutamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Methoxsalen may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Clorazepic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Dexmedetomidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Phentolamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Thiabendazole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Gadobenic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Propantheline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Dicyclomine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Pentoxifylline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Oxazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Dacarbazine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Terbutaline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Amantadine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Maprotiline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Isoniazid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Rizatriptan may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Mepivacaine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Methyldopa may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Dopamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Azathioprine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Auranofin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Salbutamol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Levobupivacaine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Ganciclovir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Edrophonium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Metyrapone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Isosorbide mononitrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Phylloquinone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Mycophenolic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Tolterodine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Memantine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lubiprostone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Abacavir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Amoxicillin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Dimethyl sulfoxide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Flucytosine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Capecitabine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Sibutramine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Tiludronic acid may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Doxacurium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Flavoxate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Bupropion may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Trimetrexate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "Cilostazol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Guanethidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Ifosfamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Flumazenil may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Fomepizole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Estazolam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Metoclopramide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Epoprostenol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Gemfibrozil may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Iodixanol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Varenicline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Arformoterol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Hydralazine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Tiotropium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Amrinone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Oxybenzone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Fenproporex may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Bromazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Valganciclovir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Sorbitol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Lorcaserin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Pegaptanib may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Milnacipran may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "Lofexidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Ezogabine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Migalastat may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Pentaerythritol tetranitrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Ipilimumab may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Icatibant may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Prasugrel may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Doripenem may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Nalmefene may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Levocetirizine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Telavancin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Flupirtine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Dalfampridine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Desvenlafaxine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Gadofosveset trisodium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Methyltestosterone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Dimercaprol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Mangafodipir may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Methylnaltrexone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Plerixafor may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Pralatrexate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Tiopronin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Triethylenetetramine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Ioflupane I 123 may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Deferiprone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "N methylnicotinamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Ruxolitinib may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Peginesatide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Aclidinium may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Teduglutide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Formestane may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Canagliflozin may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Canagliflozin may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Canagliflozin may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Canagliflozin may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Canagliflozin may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Canagliflozin may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Canagliflozin may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Canagliflozin may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Canagliflozin may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Canagliflozin may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Canagliflozin may increase the excretion rate of Magnesium hydroxide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Canagliflozin may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Canagliflozin may increase the excretion rate of Pentastarch which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Canagliflozin may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Canagliflozin may increase the excretion rate of Chromic chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Canagliflozin may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Canagliflozin may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Canagliflozin may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Canagliflozin may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Canagliflozin may increase the excretion rate of Isosulfan blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Canagliflozin may increase the excretion rate of Technetium Tc 99m mebrofenin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Canagliflozin may increase the excretion rate of Technetium Tc 99m oxidronate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Canagliflozin may increase the excretion rate of Florbetaben 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Canagliflozin may increase the excretion rate of Florbetapir 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Canagliflozin may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Canagliflozin may increase the excretion rate of Technetium Tc 99m exametazime which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Canagliflozin may increase the excretion rate of Technetium Tc 99m pyrophosphate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Canagliflozin may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Canagliflozin may increase the excretion rate of Etoperidone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Canagliflozin may increase the excretion rate of Lorpiprazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Canagliflozin may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Canagliflozin may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Canagliflozin may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Canagliflozin may increase the excretion rate of Bisoxatin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Canagliflozin may increase the excretion rate of Blonanserin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Canagliflozin may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Canagliflozin may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Canagliflozin may increase the excretion rate of Tegafur which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Canagliflozin may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Canagliflozin may increase the excretion rate of Imidafenacin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Canagliflozin may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Canagliflozin may increase the excretion rate of Picosulfuric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Canagliflozin may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Canagliflozin may increase the excretion rate of Choline C 11 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Canagliflozin may increase the excretion rate of Magnesium trisilicate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Canagliflozin may increase the excretion rate of Sacubitril which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Canagliflozin may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Canagliflozin may increase the excretion rate of Synthetic Conjugated Estrogens A which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Canagliflozin may increase the excretion rate of Synthetic Conjugated Estrogens B which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Canagliflozin may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Canagliflozin may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Canagliflozin may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Canagliflozin may increase the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Canagliflozin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Canagliflozin may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Canagliflozin may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Canagliflozin may increase the excretion rate of Phosphoric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Canagliflozin may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Canagliflozin may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Canagliflozin may increase the excretion rate of Potassium perchlorate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Canagliflozin may increase the excretion rate of Sodium sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Canagliflozin may increase the excretion rate of Magnesium carbonate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Canagliflozin may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Canagliflozin may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Canagliflozin may increase the excretion rate of Fludeoxyglucose 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Canagliflozin may increase the excretion rate of Iobenguane sulfate I 123 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Canagliflozin may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Canagliflozin may increase the excretion rate of Polyethylene glycol 400 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Canagliflozin may increase the excretion rate of Potassium nitrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Canagliflozin may increase the excretion rate of N acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Canagliflozin may increase the excretion rate of Eucalyptus oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Canagliflozin may increase the excretion rate of Selenious acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "Canagliflozin may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Canagliflozin may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Canagliflozin may increase the excretion rate of Chromium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Canagliflozin may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Canagliflozin may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Canagliflozin may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Canagliflozin may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Canagliflozin may increase the excretion rate of DL Methylephedrine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Canagliflozin may increase the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Canagliflozin may increase the excretion rate of Clove oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Canagliflozin may increase the excretion rate of Evening primrose oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Canagliflozin may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Canagliflozin may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Canagliflozin may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Canagliflozin may increase the excretion rate of Etafedrine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Canagliflozin may increase the excretion rate of Antithrombin III human which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Canagliflozin may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Canagliflozin may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Canagliflozin may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Canagliflozin may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Canagliflozin may increase the excretion rate of Isoflavone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Canagliflozin may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Canagliflozin may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Canagliflozin may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Canagliflozin may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Canagliflozin may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Canagliflozin may increase the excretion rate of Levosalbutamol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Canagliflozin may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Canagliflozin may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Canagliflozin may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Canagliflozin may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Canagliflozin may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Canagliflozin may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Canagliflozin may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Canagliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Canagliflozin may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Canagliflozin may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Canagliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Canagliflozin may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Canagliflozin may increase the excretion rate of Potassium sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Canagliflozin may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Canagliflozin may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Canagliflozin may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Canagliflozin may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Canagliflozin may increase the excretion rate of Chromous sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Canagliflozin may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Pyrithione may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Canagliflozin may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Canagliflozin may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Canagliflozin may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Canagliflozin may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Canagliflozin may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Canagliflozin may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Canagliflozin may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Canagliflozin may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Canagliflozin may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Canagliflozin may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Canagliflozin may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Canagliflozin may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lamotrigine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Nifedipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "Tramadol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Topiramate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "Methadone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Cetirizine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Buspirone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "Chloroquine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Flurazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Diazepam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Ranitidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Fenofibrate may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Promethazine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Naloxone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Ketazolam may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Fesoterodine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Canagliflozin may increase the excretion rate of Estradiol acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Canagliflozin may increase the excretion rate of Estradiol cypionate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Canagliflozin may increase the excretion rate of Estradiol dienanthate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Canagliflozin may increase the excretion rate of Estradiol valerate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Codeine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Meperidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Fentanyl may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Canagliflozin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Canagliflozin may increase the excretion rate of Strontium chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Potassium cation may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Bepotastine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Isotretinoin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Permethrin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Cyclosporine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Sirolimus can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The serum concentration of Digitoxin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Temsirolimus can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The serum concentration of Cobimetinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The serum concentration of Trastuzumab emtansine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The serum concentration of Romidepsin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The serum concentration of Panobinostat can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The serum concentration of Pomalidomide can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The serum concentration of Dabrafenib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The serum concentration of Ceritinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Osimertinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Venetoclax can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The serum concentration of Vinflunine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Talazoparib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Dacomitinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The serum concentration of Copanlisib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The serum concentration of Dasatinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The serum concentration of Tolvaptan can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The serum concentration of Bendamustine can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The serum concentration of Binimetinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The serum concentration of Bortezomib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The serum concentration of Cabergoline can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The serum concentration of Axitinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The serum concentration of Abemaciclib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Canagliflozin can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "Potassium alum may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11107",
                        "description": "Potassium bitartrate may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13620",
                        "description": "Potassium gluconate may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13831",
                        "description": "Potassium permanganate may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13977",
                        "description": "Potassium carbonate may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14492",
                        "description": "Potassium triiodide may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11153",
                        "description": "Potassium hydroxide may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13735",
                        "description": "Potassium guaiacolsulfonate may increase the hyperkalemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Mefenamic acid"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Diflunisal"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Eltrombopag"
                    },
                    {
                        "drugbank-id": "DB13609",
                        "description": "The metabolism of Canagliflozin can be decreased when combined with Umifenovir"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of hypoglycemia can be increased when Cinnarizine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of hypoglycemia can be increased when Flunarizine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of hypoglycemia can be increased when Tranilast is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of hypoglycemia can be increased when Agmatine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Darodipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Niludipine"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Caroverine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Fish oil"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of hypoglycemia can be increased when Felodipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of hypoglycemia can be increased when Bepridil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of hypoglycemia can be increased when Emopamil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Protokylol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Racepinephrine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Deoxyepinephrine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Ephedrine is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Sildenafil can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Simvastatin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The serum concentration of Vardenafil can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Saquinavir can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Rivaroxaban can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Ticagrelor can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Liothyronine"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of hypoglycemia can be increased when Benazepril is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Canagliflozin can be increased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Butabarbital"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Canagliflozin may increase the hypotensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Canagliflozin may increase the hypotensive activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Canagliflozin may increase the hypotensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Canagliflozin may increase the hypotensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Canagliflozin may increase the hypotensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Canagliflozin may increase the hypotensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Canagliflozin may increase the hypotensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Canagliflozin may increase the hypotensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Canagliflozin may increase the hypotensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Canagliflozin may increase the hypotensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Canagliflozin may increase the hypotensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Canagliflozin may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Canagliflozin may increase the hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Canagliflozin may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Canagliflozin may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Canagliflozin may increase the hypotensive activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Canagliflozin may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Canagliflozin may increase the hypotensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Canagliflozin may increase the hypotensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Canagliflozin may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Canagliflozin may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Canagliflozin may increase the hypotensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Canagliflozin may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Canagliflozin may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Canagliflozin may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Canagliflozin may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Canagliflozin may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Canagliflozin may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Canagliflozin may increase the hypotensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Canagliflozin may increase the hypotensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Canagliflozin may increase the hypotensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Canagliflozin may increase the hypotensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Canagliflozin may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Baclofen"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Canagliflozin may decrease the excretion rate of Metildigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Canagliflozin may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of hypoglycemia can be increased when Sotalol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of hypoglycemia can be increased when Canagliflozin is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Pindolol"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Practolol"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Nebivolol"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bopindolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The therapeutic efficacy of Indenolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The therapeutic efficacy of Arotinolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The therapeutic efficacy of Levobetaxolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The therapeutic efficacy of Anisodamine can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The therapeutic efficacy of Bucindolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The therapeutic efficacy of Esatenolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The therapeutic efficacy of Cloranolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The therapeutic efficacy of Mepindolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The therapeutic efficacy of Epanolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The therapeutic efficacy of Tertatolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "The therapeutic efficacy of Dexpropranolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Propranolol"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Propafenone"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The therapeutic efficacy of Metoprolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The therapeutic efficacy of Timolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The therapeutic efficacy of Acebutolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The therapeutic efficacy of Nadolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The therapeutic efficacy of Celiprolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The therapeutic efficacy of Talinolol can be increased when used in combination with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The therapeutic efficacy of Canagliflozin can be increased when used in combination with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Canagliflozin may decrease the excretion rate of Lefamulin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of hyperglycemia can be increased when Mometasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednisone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The risk or severity of hyperglycemia can be increased when Cortisone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of hyperglycemia can be increased when Trilostane is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00223",
                        "description": "The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00240",
                        "description": "The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00253",
                        "description": "The risk or severity of hyperglycemia can be increased when Medrysone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00288",
                        "description": "The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00596",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00663",
                        "description": "The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00838",
                        "description": "The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00846",
                        "description": "The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00896",
                        "description": "The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01130",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01260",
                        "description": "The risk or severity of hyperglycemia can be increased when Desonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06781",
                        "description": "The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06786",
                        "description": "The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13158",
                        "description": "The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13664",
                        "description": "The risk or severity of hyperglycemia can be increased when Formocortal is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13728",
                        "description": "The risk or severity of hyperglycemia can be increased when Halometasone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14538",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14541",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14543",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14544",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00873",
                        "description": "The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14634",
                        "description": "The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14643",
                        "description": "The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Ubrogepant can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "Thyrotropin alfa may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "Liotrix may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "Tiratricol may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "Thyroid porcine may decrease the hypoglycemic activities of Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Rimegepant can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "Canagliflozin may decrease the excretion rate of Tucatinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Ziconotide is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "Canagliflozin may increase the diuretic activities of Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Octreotide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Canagliflozin can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of hypotension can be increased when Ibudilast is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The risk or severity of hypotension can be increased when Avanafil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The risk or severity of hypotension can be increased when Udenafil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The risk or severity of hypotension can be increased when Doxofylline is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The risk or severity of hypotension can be increased when Mirodenafil is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The risk or severity of hypotension can be increased when Fostamatinib is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Canagliflozin can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB15093",
                        "description": "The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Somapacitan"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Pralsetinib can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Berotralstat can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The serum concentration of Relugolix can be increased when it is combined with Canagliflozin"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}